获取途径

作者

Xiubin Jia Qi Wu Xiaoyong Zhang Hequn Lin Jiahui Gong Hui Ye Xueli Hu Zhaoxia Liang Danqing Chen Wei Zhu & …Luyu Ma

作者单位

³Key Laboratory for Molecular Medicine and Chinese Medicine Preparations, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China ²Department of Obstetrics, School of Medicine, Women’s Hospital, Zhejiang University, Hangzhou, 310006, Zhejiang, China ¹Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250000, Shandong, China

刊名

Cardiovascular Diabetology

关键词

Gestational diabetes mellitus Hypertensive disorders of pregnancy Acetyl-L-carnitine Metabolomics Lipidomics

摘要

Background Gestational diabetes mellitus and hypertensive disorders of pregnancy are common metabolic complications during pregnancy. GDM is an independent risk factor for HDP, while HDP is a major contributor to maternal and perinatal morbidity and mortality. Reliable early tools for identifying women with GDM who are at risk of subsequently developing HDP remain limited. This study aimed to integrate metabolomic, lipidomic, and clinical data to identify reproducible candidate biomarkers ass...更多

Background Gestational diabetes mellitus and hypertensive disorders of pregnancy are common metabolic complications during pregnancy. GDM is an independent risk factor for HDP, while HDP is a major contributor to maternal and perinatal morbidity and mortality. Reliable early tools for identifying women with GDM who are at risk of subsequently developing HDP remain limited. This study aimed to integrate metabolomic, lipidomic, and clinical data to identify reproducible candidate biomarkers associated with subsequently diagnosed HDP in women with GDM and to characterize the accompanying metabolic and lipidomic alterations. Methods In this prospective exploratory biomarker study, a discovery cohort and a validation cohort were recruited. Serum samples collected at 24–28 weeks of gestation were analyzed using untargeted and targeted metabolomics. Lipidomics was performed to complement the metabolomic analysis and characterize lipid-related alterations. A combined predictive model was constructed using logistic regression, and its predictive performance was evaluated using receiver operating characteristic analysis. Results Untargeted metabolomics identified lower serum acetyl-L-carnitine in the GDMHDP group than in the GDM group, and this difference was confirmed by targeted LC–MS/MS in the validation cohort. The combined ALC–diastolic blood pressure model achieved an area under the curve of 0.907 in the discovery cohort and 0.886 in the validation cohort. Adding ALC to DBP improved discrimination and reclassification in both cohorts. Multi-omics analysis showed complementary and partly distinct lipid associations with ALC and DBP. Lower ALC was associated with selected ceramide and monolysocardiolipin species, as well as with lipid patterns consistent with altered fatty-acid handling, whereas DBP showed a partly distinct pattern of lipid correlations. Conclusions Reduced serum ALC at 24–28 weeks of gestation was reproducibly associated with GDM complicated by HDP. Combining ALC with DBP improved discrimination between GDMHDP and uncomplicated GDM, suggesting complementary metabolic and hemodynamic information. Given the modest number of GDMHDP cases and the single-center design, these findings should be interpreted as exploratory and hypothesis-generating; they support further evaluation of ALC as a candidate metabolic marker but require confirmation in larger independent cohorts.收起

文献类型

期刊

浏览量

1